论文信息 - Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353 - 字舞流文

Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353

P. Sax | D. Haas | E. Acosta | B. Taiwo | B. Ha | B. Berzins | Kimberly Smith | R. Gulick | C. Godfrey | J. Kumwenda | C. Wallis | Lu Zheng | B. Sha | B. Jarocki | E. Hawkins | A.T.S. Hernandez | Cornelius N. Van Dam | Maxine Olefsky | Amesika N. Nyaku | G. Tegha | T. Sullivan | C. V. Van Dam